Cutler Group’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-209
Closed -$12K 2147
2021
Q4
$12K Sell
209
-2,000
-91% -$115K ﹤0.01% 1613
2021
Q3
$130K Buy
2,209
+2,059
+1,373% +$121K 0.01% 856
2021
Q2
$13K Hold
150
﹤0.01% 1645
2021
Q1
$12K Sell
150
-1,230
-89% -$98.4K ﹤0.01% 1584
2020
Q4
$125K Buy
+1,380
New +$125K 0.01% 721
2020
Q3
Sell
-1,300
Closed -$44K 1855
2020
Q2
$44K Buy
+1,300
New +$44K ﹤0.01% 881
2020
Q1
Sell
-700
Closed -$13K 1610
2019
Q4
$13K Buy
+700
New +$13K ﹤0.01% 1188
2019
Q3
Hold
0
1680
2019
Q2
Hold
0
1771
2019
Q1
Hold
0
1707
2018
Q4
Hold
0
1798
2018
Q3
Sell
-1,000
Closed -$11K 1803
2018
Q2
$11K Buy
+1,000
New +$11K ﹤0.01% 1267